Challenges in HCC
Experts Discuss Challenges in Advanced Hepatocellular Carcinoma Management

Released: August 22, 2022

Heinz-Josef Klumpen
Heinz-Josef Klumpen, MD, PhD
Chris Verslype
Chris Verslype, MD, PhD

Activity

Progress
1
Course Completed

In this podcast episode from Clinical Care Options (CCO), Heinz-Josef Klumpen, MD, PhD, and Chris Verslype, MD, PhD, discuss challenges in selecting and sequencing therapy for patients with advanced hepatocellular carcinoma. Topics include:

  • Factors to consider when selecting second-line therapy including the role of TKIs and planning for multiple lines of therapy
  • Factors to consider before selecting frontline immunotherapy
  • Role of TKIs in the frontline
  • Impact of Child-Pugh status on the efficacy of immunotherapy/VEGF inhibitor combination therapy
  • Real-world evidence on frontline immunotherapy/VEGF combination therapy